Correction to: Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection

Clin Drug Investig. 2021 Mar;41(3):291. doi: 10.1007/s40261-021-01014-9.

¹ Department of Gastroenterology and Hepatology, Federal Research Center for Nutrition, Biotechnology and Food Safety, Kashirskoe shosse, 21, Moscow, 115446, Russian Federation. [email protected].
² Clinical and Diagnostic Department, Krasnoyarsk Regional Center for Prevention and Control of AIDS and Infectious Diseases, Krasnoyarsk, Russian Federation.
³ Hepatolog, LLC, Samara, Russian Federation.
⁴ Clinical Research, Gilead Sciences, Foster City, CA, USA.
⁵ Department of Internal Medicine, Tartu University Hospital, Tartu, Estonia.
⁶ Moscow Regional Center for Prevention and Control of AIDS and Infectious Diseases, Moscow, Russian Federation.
⁷ Department of Infectious Diseases, Military Medical Academy, St Petersburg, Russian Federation.

No abstract available

Publication types